Amoxi-Tabs C®-250

Tablet Oral

Broad-spectrum antibiotic with bacterial resistance inhibitor


Amoxicillin base 200 mg, clavulanic acid 50 mg; excipients q.s. ad 1 tablet.


For the treatment of periodontal infections caused by susceptible strains (aerobic and anaerobic bacterias). Treatment of skin and soft tissues infections caused by susceptible species of Staphylococcus spp. E. coli, Pasteurella spp. and Streptococcus spp. Treatment of respiratory tract and urinary tract infections, including those caused by susceptible species of E. coli. Osteomyelitis treatment and other bacterial complications susceptible to amoxicillin.

Dosage and Administration

1 tablet/16 kg every 8 - 12 hours for at least 3 days. Administer through oral route.

Commercial Presentation

Box x 10 tablets ,

registro SAGARPA

México Registro SAGARPA Q-0616-030